thestarphoenix.com
Competition watchdog alleges brand-name pharma firms are denying generic companies the medicines they need for tests
Companies have ‘increasingly’ been denying or delaying sales of their medicines, the Competition Bureau of Canada charges in court documents obtained by the National Post